Prognostic and Clinic Pathological Value of Cx43 Expression in Glioma: A Meta-Analysis.

Abstract

Gap junctional intercellular communication (GJIC) composed of connexin proteins is considered vital to cancer onset and progression since 50 years ago based on Lowenstein and Kano's works, however altered expression of connexins is still a lesser known "hallmark" of cancer. Although many studies support the hypothesis that connexins are tumor suppressors, recent evidence indicates that, in some tumor types including glioma, they may play contradictory role in some specific stages of tumor progression. We thus conduct a meta-analysis to evaluate the prognostic role of Cx43 in glioma for the unanswered questions that whether Cx43 is a beneficial or insalubrity factor for glioma. Eight studies with 1,706 patients were included for meta-analysis. The results showed that Cx43 expression was a clearly negative factor with tumor grades (I 2 = 34%, P < 0.001) and beneficial for OS (n = 3, HR 2.62, 95%CI 1.47-4.68; P = 0.001). Subgroup analysis also found that Cx43 had different expression in Asian young patients vs. other groups. In conclusion, this article summarize the prognostic value of Cx43 and offer a clinical evidence for the notion that Cx43 is generally a tumor suppressor and beneficial for the patients' survival time.

• Authors: Chao Zhang, Cheng-Fen Liu, An-Bin Chen, Zhong Yao, Wei-Guo Li, Shu-Jun Xu, Xiang-Yu Ma
• Journal: Frontiers in oncology (Front Oncol) Vol. 9 Pg. 1209 ( 2019) ISSN: 2234-943X [Print] Switzerland
• PMID: 31781504 (Publication Type: Systematic Review)
• Copyright: Copyright © 2019 Zhang, Liu, Chen, Yao, Li, Xu and Ma.